跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Neoflu - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Neoflu
Approved
STANDARD
Neoflu
Lloyd Laboratories, Inc. / Gold Life Distribution Phils., Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2c4a181a9d7ce592
Company
Lloyd Laboratories, Inc. / Gold Life Distribution Phils., Inc.,
Type
Standard
Approval Details
Approval Id
2c4a181a9d7ce592
Drug Approval Philippines Name
Neoflu
Product Name
Neoflu
Registration Number
DRP-7759
Brand Name
Neoflu
Generic Name
Paracetamol + Phenylephrine HCl + Chlorphenamine Maleate
Dosage Form
Syrup
Dosage Strength
125 mg/6.25 mg/500 mcg per 5 mL
Manufacturer
Lloyd Laboratories, Inc. / Gold Life Distribution Phils., Inc.,
Trader
GOLD LIFE DISTRIBUTORS PHILS., INC.
Distributor
999 Seth Pharmaceuticals, Inc.
Issuance Date
27 September 2024
Expiry Date
21 January 2030
Pharmacologic Category
Analgesic/ Nasal Decongestant/ Antihistamine
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2c4a181a9d7ce592
Type
Standard
Back to Philippines FDA Approvals